Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of dinitrochlorobenzene (DNCB) in patients with early HIV infection
by monitoring immunologic parameters and serum HIV RNA. To facilitate the understanding of
possible alterations in the immunological status of the HIV+ patient cohort.